JP2024510762A5 - - Google Patents
Info
- Publication number
- JP2024510762A5 JP2024510762A5 JP2023557098A JP2023557098A JP2024510762A5 JP 2024510762 A5 JP2024510762 A5 JP 2024510762A5 JP 2023557098 A JP2023557098 A JP 2023557098A JP 2023557098 A JP2023557098 A JP 2023557098A JP 2024510762 A5 JP2024510762 A5 JP 2024510762A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- pyridine
- imidazo
- ethoxy
- sinnoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2021/081254 WO2022193166A1 (en) | 2021-03-17 | 2021-03-17 | Selective modulators of ataxia telangiectasia mutated (atm) kinase and uses thereof |
| CNPCT/CN2021/081254 | 2021-03-17 | ||
| PCT/CN2022/080905 WO2022194138A1 (en) | 2021-03-17 | 2022-03-15 | Selective modulators of ataxia telangiectasia mutated (atm) kinase and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024510762A JP2024510762A (ja) | 2024-03-11 |
| JP2024510762A5 true JP2024510762A5 (https=) | 2025-03-12 |
| JP7833477B2 JP7833477B2 (ja) | 2026-03-19 |
Family
ID=83321678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023557098A Active JP7833477B2 (ja) | 2021-03-17 | 2022-03-15 | 血管拡張性失調症変異（ａｔｍ）キナーゼの選択的モジュレーターおよびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240207263A1 (https=) |
| EP (1) | EP4308569A4 (https=) |
| JP (1) | JP7833477B2 (https=) |
| KR (1) | KR20230157467A (https=) |
| CN (1) | CN117412972A (https=) |
| AU (1) | AU2021433713A1 (https=) |
| CA (1) | CA3213823A1 (https=) |
| WO (2) | WO2022193166A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021433713A1 (en) * | 2021-03-17 | 2023-09-28 | Suzhou Zanrong Pharma Limited | Selective modulators of ataxia telangiectasia mutated (atm) kinase and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| DE69720965T2 (de) | 1996-02-13 | 2004-02-05 | Astrazeneca Ab | Chinazolinderivate und deren verwendung als vegf hemmer |
| NZ331191A (en) | 1996-03-05 | 2000-03-27 | Zeneca Ltd | 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| WO2010048582A1 (en) | 2008-10-24 | 2010-04-29 | Irm Llc | Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues |
| NO2714752T3 (https=) | 2014-05-08 | 2018-04-21 | ||
| GB201516504D0 (en) | 2015-09-17 | 2015-11-04 | Astrazeneca Ab | Imadazo(4,5-c)quinolin-2-one Compounds and their use in treating cancer |
| GB201519406D0 (en) | 2015-11-03 | 2015-12-16 | Astrazeneca Ab | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer |
| WO2019057757A1 (en) * | 2017-09-20 | 2019-03-28 | Astrazeneca Ab | 1,3-DIHYDROIMIDAZO [4,5-C] CINNOLIN-2-ONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER |
| CN115636833B (zh) * | 2018-09-14 | 2024-11-29 | 苏州赞荣医药科技有限公司 | 作为ATM激酶选择性调节剂的取代的咪唑并[4,5-c]噌啉-2-酮化合物及其用途 |
| AU2021433713A1 (en) * | 2021-03-17 | 2023-09-28 | Suzhou Zanrong Pharma Limited | Selective modulators of ataxia telangiectasia mutated (atm) kinase and uses thereof |
-
2021
- 2021-03-17 AU AU2021433713A patent/AU2021433713A1/en active Pending
- 2021-03-17 WO PCT/CN2021/081254 patent/WO2022193166A1/en not_active Ceased
-
2022
- 2022-03-15 WO PCT/CN2022/080905 patent/WO2022194138A1/en not_active Ceased
- 2022-03-15 CN CN202280035588.7A patent/CN117412972A/zh active Pending
- 2022-03-15 JP JP2023557098A patent/JP7833477B2/ja active Active
- 2022-03-15 CA CA3213823A patent/CA3213823A1/en active Pending
- 2022-03-15 EP EP22770491.3A patent/EP4308569A4/en active Pending
- 2022-03-15 US US18/551,188 patent/US20240207263A1/en active Pending
- 2022-03-15 KR KR1020237035363A patent/KR20230157467A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7461390B2 (ja) | メニン－ｍｌｌ相互作用の阻害剤 | |
| CN112625028B (zh) | 用于抑制shp2活性的化合物和组合物 | |
| CA2984259C (en) | Combinations of inhibitors of irak4 with inhibitors of btk | |
| KR102536029B1 (ko) | 메닌-ｍｌｌ 상호작용의 억제제 | |
| US10308660B2 (en) | Compounds and compositions for inhibiting the activity of SHP2 | |
| US11046699B2 (en) | Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic uses | |
| JP2023545274A (ja) | 癌を処置する化合物および方法 | |
| JP2011500806A5 (https=) | ||
| US10526311B2 (en) | Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity | |
| AU2019381808A1 (en) | ERK inhibitors and uses thereof | |
| UA118965C2 (uk) | 6-(5-гідрокси-1н-піразол-1-іл)нікотинамідні інгібітори рнd | |
| JP7365332B2 (ja) | Ｃｄｋ８／１９阻害薬としての新規ヘテロ環式化合物 | |
| JP7426486B2 (ja) | インターフェロン遺伝子刺激因子（ｓｔｉｎｇ）のモジュレーターとしての複素環式化合物 | |
| TW200811159A (en) | Therapeutic compounds | |
| EP3219329A1 (en) | Combinations of copanlisib | |
| JP2022500428A5 (https=) | ||
| JP2011510028A5 (https=) | ||
| JP2013523814A5 (https=) | ||
| TW202341982A (zh) | Ｃｄｋ２抑制劑及其用途 | |
| JPWO2019216294A5 (https=) | ||
| JP2024510762A5 (https=) | ||
| US20250345339A1 (en) | Doses and regimens of her2 inhibitors | |
| EP4301371A1 (en) | Substituted 3,6-dihydro-2h-1,3,4-oxadiazin-2-ones for the treatment of sarcoma | |
| US20210369724A1 (en) | Combination of atr kinase inhibitors with 2,3-dihydroimidazo[1,2-c]quinazoline compounds | |
| WO2020030924A1 (en) | Thiazoleureas as anticancer agents |